Schott to Present New Syringe Format at Pharmapack 2020
The company will showcase the syriQ BioPure syringe in a 2.25-mL format for autoinjectors at Pharmapack in Paris, France from Feb. 5¬¬–6, 2020.
Schott announced it will showcase the syriQ BioPure syringe in a in a 2.25-mL format for autoinjectors at Pharmapack in Paris, France from Feb. 5–6, 2020. This format is beneficial for administering highly viscous biologics by autoinjector.
“The standard 1-mL long glass syringe is too small in volume for the increase in bioavailability [of biologic drugs], yet a container beyond 3 mL would be too big for administration,” said Anil Kumar Busimi, senior global product manager for the Schott iQ Platform, in the press release. “The new 2.25-mL long syringes therefore ensure the efficiency of the treatment, while also making the administration with an autoinjector easier and more comfortable for the patient.”
According to a company press release, BioPure syringes are manufactured with processes that lower tungsten and adhesive residuals, and the materials are designed for an extractables and leachables profile that ensures drug stability. In addition, accurate dimensions ensure device compatibility.
Source: Schott
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution
June 20th 2023Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.
